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A B S T R A C T
A 69-year-old man underwent repeat percutaneous coronary intervention for in-stent restenosis in the
obtuse marginal artery 8 months after biolimus-eluting stent (2.5  28 mm Nobori stent, Terumo, Tokyo,
Japan) implantation. Coronary angiography showed focal stenosis in the distal part of the stent.
Intravascular ultrasound revealed low echoic heterogeneous intimal tissue. Optical coherence
tomography also revealed a heterogeneous ﬁnding classiﬁed as a layered pattern. Coronary angioscopy
detected a white mass with a paste-like appearance at the stenosis extending around the in-stent
restenosis as a thin membrane where stent strut could be seen transparently. A small part of the mass
was swinging in the blood stream. Coronary angioscopic imaging was beneﬁcial for the understanding of
the suspected mechanism and feature of the in-stent restenosis after second-generation stent
implantation, which was apparently different from neointimal hyperplasia after bare-metal stent
implantation.
<Learning objective: The learning objectives of this case report include understanding the mechanism
of in-stent restenosis after second-generation drug-eluting stent implantation by showing the coronary
angioscopic imaging beyond the other intravascular imaging. In particular, this case can make the
general and interventional cardiologists learn that the mechanism of in-stent restenosis <1 year is
different from that after bare-metal stent implantation.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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The use of drug-eluting stents (DES) has dramatically decreased
the restenosis rate. However, despite DES implantation, restenosis
still occurs at an incidence rate of 5–10%. The mechanism of in-
stent restenosis (ISR) might differ between DES and bare-metal
stents (BMS) potentially because of the polymer or drug on the
stent strut in DES. The mechanism of ISR after biolimus-eluting
stent (BES) implantation, a second-generation stent, is not well
known. We experienced a case of ISR 8 months after BES
implantation that could be evaluated by coronary angioscopy
(CAS) besides intravascular ultrasound (IVUS) and optical coher-
ence tomography (OCT).
Case report
A 69-year-old man underwent coronary angiography for angina
pectoris. His medical history included old anteroseptal and inferior* Corresponding author at: Division of Cardiology, The Junshukai Medical
Foundation Higashiyama Clinic, 5-103 Higashiyama-dori, Chikusa-ku, Nagoya-shi,
Aichi-ken 464-0807, Japan. Tel.: +81 52 781 1235; fax: +81 52 789 7000.
E-mail address: shigeito918@gmail.com (S. Ito).
http://dx.doi.org/10.1016/j.jccase.2015.06.004
1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsmyocardial infarction, vasospastic angina, chronic atrial ﬁbrilla-
tion, type 2 diabetes mellitus, and dyslipidemia. He had undergone
percutaneous coronary intervention (PCI) for the coronary steno-
ses in the left anterior descending coronary artery (LAD) and
obtuse marginal artery (OM) 8 months previously. A BES was
implanted for a calciﬁed lesion in the LAD after rotational ablation
(Nobori 2.5  28 mm, Terumo, Tokyo, Japan) and for the tandem
lesion in the OM after balloon pre-dilataion (Nobori 2.5  28 mm)
(Fig. 1a and b). After 8 months the angina pectoris recurred and he
underwent coronary angiography and an ISR was detected in the
Nobori stent implanted in the OM. On angiographic examination,
the ISR was morphologically eccentric and focal (lesion length
7.7 mm) in the distal part of the stent, where minimal lumen
diameter (MLD) existed at baseline (Fig. 1c). No ISR was observed
in the LAD. His medication included aspirin 100 mg, clopidogrel
sulfate 75 mg, warfarin 2 mg, benidipine hydrochloride 4 mg,
diltiazem hydrochloride R 100 mg, atorvastatin calcium hydrate
10 mg, isosorbide dinitrate 40 mg, sitagliptin phosphate hydrate
50 mg, and voglibose 0.9 mg per day at the time of PCI for ISR. Dual
antiplatelet therapy was maintained after index PCI. Two months
later, he underwent balloon angioplasty for the ISR by using a
2.5  13 mm cutting balloon followed by a paclitaxel-eluting
balloon SeQuent Please1 (2.5  26 mm; B. Braun, Melsungen, reserved.
Fig. 1.
Coronary angiograms. (a) Before index percutaneous coronary intervention (PCI). A tandem lesion in the obtuse marginal artery was found. No calciﬁcation or
thrombus was detected. (b) After index PCI. Good result was obtained after 2.5  28 mm Nobori stent implantation. (c) At follow-up. Focal in-stent restenosis was
detected in the distal part of the previously deployed Nobori stent in a minimal lumen diameter site. (d) After cutting balloon dilatation followed by paclitaxel-
eluting balloon OptiCross1(2.5  26 mm). Stent-like result was found with no dissection or thrombus.
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Boston Scientiﬁc Corp., Natick, MA, USA), OCT (IlumenTM OCT
Imaging System, St. Jude Medical Inc., St. Paul, MN, USA), and CAS
guidance (Smart-iTM, iHeartmedical, Tokyo, Japan). No improve-
ment in angiographic ﬁndings was observed in the follow-up
angiography. IVUS revealed a heterogeneous low echoic plaque
with a little lower echogenicity near the stent struts (Fig. 2a). OCT
(Fig. 2b) revealed a heterogeneous intimal hyperplasia component
(classiﬁed as layered [1]). Delayed healing and inter-strut halo in
the stent were observed in the area without ISR (Fig. 2c). CAS
showed a white mass that looked like paste extending around ISR
as a thin membrane where stent strut could be seen transparently
(Fig. 3a and b). A small part of mass was swinging in the blood
stream (Fig. 3c). The intensity of the intimal hyperplasia on IVUS
and OCT is apparently lower than that usually found in ISR after
BMS implantation, which usually shows homogenous highintensity. Neointimal tissue could be easily dilated at 6 atm.
The OCT ﬁnding after cutting balloon dilatation showed no
residual plaque or intimal ﬂaps in the stent indicating that the
plaque was detached and ﬂown away distally after balloon
dilatation (Fig. 2d). We decided to treat this lesion with a
paclitaxel-eluting balloon SeQuent Please1, not with a stent,
based on its stent-like result. Final coronary angiograms showed
excellent results without any residual stenosis or slow ﬂow/distal
embolism (Fig. 1d).
Discussion
In this case, we demonstrated an interesting CAS image
suggesting the mechanism of ISR after BES stent implantation.
This ﬁnding in association with IVUS and OCT images is
different from that of ISR after BMS implantation, where intimal
Fig. 2.
Intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Each black arrow indicates the location of IVUS or OCT image in the incorporated
angiography. (a) IVUS before percutaneous coronary intervention (PCI). Two representative images are shown. A low echoic heterogeneous plaque was detected.
(b) OCT before and after PCI. At in-stent restenosis site, a heterogeneous (layered) intimal hyperplasia component was detected before PCI, where no residual
intimal hyperplasia was found at in-stent restenosis site. At reference site before PCI, delayed healing and inter-strut halo in the stent were observed in the area
without in-stent restenosis.
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Fig. 3.
Coronary angioscopy (CAS) before percutaneous coronary intervention (PCI). Each black arrow indicates the location of CAS image in the incorporated
angiography. (a) At the minimal lumen diameter site. The vascular lumen was narrowed by the white paste-like soft tissue. (b) Delayed healing of the
nonrestenotic site. Similar tissue was detected in the lesion near the in-stent restenosis. Stent strut could be seen transparently. (c) The swinging piece of
neointimal tissue component.
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[2]. Although, unfortunately, we did not perform plaque retrieval
as a pathological specimen, white thrombus or inﬂammatory
products or their complexes were possibly [3–5] present.
Late and very late stent thrombosis or restenosis (>1 year) is a
challenging problem in patients who underwent DES implantation.
It may occur at a low annual incidence of 0.2–0.6%, however it
could be lethal if it occurs. Nagai et al. reported on patients with
DES ISR lesions who showed heterogeneous intimal hyperplasia
assessed by OCT and histopathology [6]. Thus, its mechanism,
prevention, and treatment are widely investigated. However, ISR
<1 year after DES implantation had not been focused on
intensively.
Araki et al. [7] characterized the in-stent neointimal tissue
components according to the restenosis phase by using radio-
frequency signals from 40-MHz IVUS, (iMAP-IVUS; Boston
Scientiﬁc Corp.) in 37 angina patients (37 lesions) who underwent
repeated PCI for the treatment of DES ISR. The percentage of lipid
components and relative necrotic volume were greater in the late
(>1 year) ISR group than in the early (21 year) ISR group. Tsujita
et al. [8] also reported similar results. DES implantation would be
associated with iMap-derived necrotic and less-ﬁbrotic neointimal
formation. Itoh et al. [4] assessed the ISR image produced by OCT
for tissue heterogeneity and neointimal hyperplasia in 100 angio-
graphic ISR lesions by using the normalized standard deviation
of OCT signal intensity (OCT-NSD) observed in neointimalhyperplasia tissue. ISR lesions were divided into homogeneous
(n = 48) and nonhomogeneous (n = 52) image groups. The preva-
lence of DES was 48% in the nonhomogeneous group and 29% in the
homogeneous group (p = 0.05). The OCT-NSD value in the
nonhomogeneous group was signiﬁcantly higher than that in
the homogeneous group. Pathological tissue showed ﬁbrin
thrombi with inﬁltrating macrophages in 12 cases of nonhomoge-
neous ISR. The nonhomogeneous ISR image visualized by OCT may
show chronic inﬂammation and ﬁbrin thrombi. Oikawa et al. [5]
directly compared IVUS and CAS imaging ﬁndings with histopath-
ological assessment of DES in ﬁrst-generation sirolimus-eluting
stent (SES). Within 1 year, 21 SES- and 8 BMS-related ISR occurred
(10.8 versus 7.5 months, respectively). Directional coronary
atherectomy was performed for histological examination. Throm-
bus and ﬁbrin depositions detected by either CAS or histopatholo-
gy were observed more frequently in the SES than in the BMS group
(92.3% vs. 25.0%, p = 0.007). CAS did not reveal red thrombus, but
showed white thrombus in six SES and two BMS cases (46.2% vs.
25.0%, p = 0.597). Histological ﬁndings demonstrated various
patterns after SES including thrombus, ﬁbrin, inﬂammatory
inﬁltrate, and collagen-matrix rich tissue, while thrombus
component was not detected in BMS. Thus, SES ISR may be
frequently associated with thrombus component. Hayashi et al. [3]
reported a similar phenomenon in a patient with ISR 6 months
after everolimus-eluting stent (EES) implantation. Diagnostic
angiography demonstrated focal ISR in the long multiple EESs.
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stenotic lesion, which was successfully dilated with a cutting
balloon. The whitish material obtained by using a distal protection
device was composed of ﬁbrin thrombi with neutrophils and small
pieces of mature ﬁbrocellular neointima. Recently, Shibuya et al.
[9] revealed natural history of heterogeneous intimal hyperplasia
assessed by OCT. Based on the nonhomogeneous features of IVUS
and OCT images, and the white paste-like CAS image, ﬁbrin
thrombi with inﬁltrating inﬂammatory cells were the suspected
pathological cause. The mechanism of ISR in this case could be
based on the delayed healing after stent implantation. As a
limitation of this case report, we did not perform histopathological
examinations and tissue characterization of the neointimal tissue
by using iMAP. Although this case report might lack novel IVUS and
OCT ﬁndings, however, strength would exist in that CAS, which
gives color, softness, and motion, and could be contrasted with
IVUS and OCT by direct visualization in vivo.
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